Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

LSX World Congress

The LSX World Congress is Europe's premier event for life science leaders, designed to connect senior decision-makers from biopharma, medtech, and healthtech sectors. It offers [...]

Go to Top